Global Structural Heart Devices Market Size- By Product, By Procedure, By End User -Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Description
Structural Heart Devices Market Introduction and Overview
According to SPER Market Research, Global Structural Heart Devices Market is estimated to reach USD 29.78 billion by 2034 with a CAGR of 9.06%.
The report includes an in-depth analysis of the Global Structural Heart Devices Market, including market size and trends, product mix, Applications, and supplier analysis. The Structural Heart Devices Market was valued at USD 12.51 billion in 2024, and it is expected to rise at a 9.06% CAGR from 2025 to 2034. Demand for structural heart devices is driven by the rising prevalence of structural heart diseases such as aortic stenosis and mitral regurgitation, particularly in aging populations. Advancements in minimally invasive technologies like TAVR and TMVR offer safer and more effective alternatives to open-heart surgery, increasing adoption. Growing awareness and improved early diagnosis of heart diseases are boosting demand for advanced therapies. Additionally, favourable reimbursement policies across several countries are supporting wider patient access, further fuelling market growth.
By Product Insights
The market is classified into heart valve devices, annuloplasty rings, occludes and delivery systems, and other products, with the heart valve devices segment generating the highest revenue. Conditions such as calcific aortic valve disease and rheumatic heart disease have a considerable healthcare impact worldwide. In the U.S., a significant share of the population suffers from heart valve disease, which is also responsible for thousands of deaths each year. These complications increase the need for efficient management and treatment, creating scope for greater utilization of heart valve devices. Furthermore, the market for advanced cardiovascular devices is supported by continuous improvements in heart valve technologies and non-invasive transcatheter replacement procedures, which are less invasive and more comfortable for patients, thereby driving market growth.
By Procedure Insights
The structural heart devices market is segmented into replacement procedures and repair procedures, with replacement procedures holding the leading share in 2024. The adoption of transcatheter heart valve replacement reflects a strong shift toward minimally invasive techniques, which are favoured by patients for their faster recovery times. Additionally, advancements in robotic-assisted heart surgery have transformed replacement approaches, allowing surgeons greater precision and control through robotic arms. Ongoing innovations in device design and procedural methods have further enhanced clinical outcomes, while key factors such as patient safety, shorter hospital stays, and improved quality of life continue to strengthen the prominence of replacement procedures in the market.
By End User Insights
The hospital segment dominated the structural heart devices market in 2024 and is expected to maintain its lead throughout the forecast period. Hospitals are equipped with advanced technologies such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR), which require specialized tools and skilled expertise. Facilities with dedicated cardiac care units and interventional cardiology departments are particularly capable of performing these procedures.
Regional Insights
North America held the largest share of the structural heart devices market in 2024, driven by the growing prevalence of cardiovascular diseases, rising cases of heart valve disorders, and supportive government initiatives that boost awareness and funding for prosthetic heart valve treatments. Furthermore, The structural heart devices market in Asia Pacific is anticipated to expand at the quickest rate during the forecast period. The market is growing due to increased elderly populations, an increase in CVD incidence, and technological advancements.
Market Competitive Landscape
The structural heart devices market is highly competitive, with numerous global and regional players striving to strengthen their market positions. Leading companies such as Abbott, Medtronic, Edwards Lifesciences, and Boston Scientific hold significant shares due to their strong portfolios of transcatheter and surgical heart valve technologies. To expand their reach and capabilities, these companies actively pursue strategies like mergers and acquisitions, partnerships, and facility expansions. Continuous investment in research and development allows them to innovate device designs, improve procedural outcomes, and incorporate advanced technologies. Smaller and emerging players also focus on niche therapies and regional expansion.
Recent Developments:
The FDA approved LUMA Vision's VERAFEYE product in April 2025, providing real-time 360° catheter navigation support for electrophysiology and structural cardiac treatments.
In November 2024, The U.S. Food and Drug Administration (FDA) granted De Novo authorization to Pi-Cardia for their unique Shortcut system. This innovative device addresses a serious coronary blockage problem and supports valve-in-valve Transcatheter Aortic Valve Replacement (TAVR) surgeries.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Product, By Procedure, By End User
Regions covered
North America, Latin America, , Europe, and Middle East & Africa
Companies Covered
Abbott, AtriCure, BIOMERICS, Boston Scientific, BRAILE, CryoLife, Edwards, JENAVALVE, LEPU, MEDICAL, LivaNova, Medtronic, NUMED.
Key Topics Covered in the Report
Global Structural Heart Devices Market Size (FY'2021-FY'2034)
Overview of Global Structural Heart Devices Market
Segmentation of Global Structural Heart Devices Market by Product (Heart valve devices, valves Annuloplasty rings, Occludes and delivery systems)
Segmentation Global Structural Heart Devices Market by Procedure (Replacement procedures, Repair procedures)
Segmentation of Global Structural Heart Devices Market by End User (Hospitals Ambulatory surgical centres, Cardiac catheterization labs, Other end user)
Statistical Snap of Global Structural Heart Devices Market
Expansion Analysis of Global Structural Heart Devices Market
Problems and Obstacles in Global Structural Heart Devices Market
Competitive Landscape in the Global Structural Heart Devices Market
Details on Current Investment in Global Structural Heart Devices Market
Competitive Analysis of Global Structural Heart Devices Market
Prominent Players in the Global Structural Heart Devices Market
SWOT Analysis of Global Structural Heart Devices Market
Global Structural Heart Devices Market Future Outlook and Projections (FY'2025-FY'2034)
Recommendations from Analyst
According to SPER Market Research, Global Structural Heart Devices Market is estimated to reach USD 29.78 billion by 2034 with a CAGR of 9.06%.
The report includes an in-depth analysis of the Global Structural Heart Devices Market, including market size and trends, product mix, Applications, and supplier analysis. The Structural Heart Devices Market was valued at USD 12.51 billion in 2024, and it is expected to rise at a 9.06% CAGR from 2025 to 2034. Demand for structural heart devices is driven by the rising prevalence of structural heart diseases such as aortic stenosis and mitral regurgitation, particularly in aging populations. Advancements in minimally invasive technologies like TAVR and TMVR offer safer and more effective alternatives to open-heart surgery, increasing adoption. Growing awareness and improved early diagnosis of heart diseases are boosting demand for advanced therapies. Additionally, favourable reimbursement policies across several countries are supporting wider patient access, further fuelling market growth.
By Product Insights
The market is classified into heart valve devices, annuloplasty rings, occludes and delivery systems, and other products, with the heart valve devices segment generating the highest revenue. Conditions such as calcific aortic valve disease and rheumatic heart disease have a considerable healthcare impact worldwide. In the U.S., a significant share of the population suffers from heart valve disease, which is also responsible for thousands of deaths each year. These complications increase the need for efficient management and treatment, creating scope for greater utilization of heart valve devices. Furthermore, the market for advanced cardiovascular devices is supported by continuous improvements in heart valve technologies and non-invasive transcatheter replacement procedures, which are less invasive and more comfortable for patients, thereby driving market growth.
By Procedure Insights
The structural heart devices market is segmented into replacement procedures and repair procedures, with replacement procedures holding the leading share in 2024. The adoption of transcatheter heart valve replacement reflects a strong shift toward minimally invasive techniques, which are favoured by patients for their faster recovery times. Additionally, advancements in robotic-assisted heart surgery have transformed replacement approaches, allowing surgeons greater precision and control through robotic arms. Ongoing innovations in device design and procedural methods have further enhanced clinical outcomes, while key factors such as patient safety, shorter hospital stays, and improved quality of life continue to strengthen the prominence of replacement procedures in the market.
By End User Insights
The hospital segment dominated the structural heart devices market in 2024 and is expected to maintain its lead throughout the forecast period. Hospitals are equipped with advanced technologies such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR), which require specialized tools and skilled expertise. Facilities with dedicated cardiac care units and interventional cardiology departments are particularly capable of performing these procedures.
Regional Insights
North America held the largest share of the structural heart devices market in 2024, driven by the growing prevalence of cardiovascular diseases, rising cases of heart valve disorders, and supportive government initiatives that boost awareness and funding for prosthetic heart valve treatments. Furthermore, The structural heart devices market in Asia Pacific is anticipated to expand at the quickest rate during the forecast period. The market is growing due to increased elderly populations, an increase in CVD incidence, and technological advancements.
Market Competitive Landscape
The structural heart devices market is highly competitive, with numerous global and regional players striving to strengthen their market positions. Leading companies such as Abbott, Medtronic, Edwards Lifesciences, and Boston Scientific hold significant shares due to their strong portfolios of transcatheter and surgical heart valve technologies. To expand their reach and capabilities, these companies actively pursue strategies like mergers and acquisitions, partnerships, and facility expansions. Continuous investment in research and development allows them to innovate device designs, improve procedural outcomes, and incorporate advanced technologies. Smaller and emerging players also focus on niche therapies and regional expansion.
Recent Developments:
The FDA approved LUMA Vision's VERAFEYE product in April 2025, providing real-time 360° catheter navigation support for electrophysiology and structural cardiac treatments.
In November 2024, The U.S. Food and Drug Administration (FDA) granted De Novo authorization to Pi-Cardia for their unique Shortcut system. This innovative device addresses a serious coronary blockage problem and supports valve-in-valve Transcatheter Aortic Valve Replacement (TAVR) surgeries.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Product, By Procedure, By End User
Regions covered
North America, Latin America, , Europe, and Middle East & Africa
Companies Covered
Abbott, AtriCure, BIOMERICS, Boston Scientific, BRAILE, CryoLife, Edwards, JENAVALVE, LEPU, MEDICAL, LivaNova, Medtronic, NUMED.
Key Topics Covered in the Report
Global Structural Heart Devices Market Size (FY'2021-FY'2034)
Overview of Global Structural Heart Devices Market
Segmentation of Global Structural Heart Devices Market by Product (Heart valve devices, valves Annuloplasty rings, Occludes and delivery systems)
Segmentation Global Structural Heart Devices Market by Procedure (Replacement procedures, Repair procedures)
Segmentation of Global Structural Heart Devices Market by End User (Hospitals Ambulatory surgical centres, Cardiac catheterization labs, Other end user)
Statistical Snap of Global Structural Heart Devices Market
Expansion Analysis of Global Structural Heart Devices Market
Problems and Obstacles in Global Structural Heart Devices Market
Competitive Landscape in the Global Structural Heart Devices Market
Details on Current Investment in Global Structural Heart Devices Market
Competitive Analysis of Global Structural Heart Devices Market
Prominent Players in the Global Structural Heart Devices Market
SWOT Analysis of Global Structural Heart Devices Market
Global Structural Heart Devices Market Future Outlook and Projections (FY'2025-FY'2034)
Recommendations from Analyst
Table of Contents
244 Pages
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Global Structural Heart Devices Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Structural Heart Devices Market
- 7. Global Structural Heart Devices Market, By Product (USD Million) 2021-2034
- 7.1. Heart valve devices
- 7.1.1. Surgical heart valves
- 7.1.2. Transcatheter heart valves
- 7.2. Annuloplasty rings
- 7.3. Occluders and delivery systems
- 7.4. Other products
- 8. Global Structural Heart Devices Market, By Procedure (USD Million) 2021-2034
- 8.1. Replacement procedures
- 8.1.1. Replacement procedures
- 8.1.2. Surgical aortic valve replacement (SAVR)
- 8.1.3. Transcatheter aortic valve replacement (TAVR)
- 8.1.4. Transcatheter mitral valve replacement (TMVR)
- 8.1.5. Other replacement procedures
- 8.2. Repair procedures
- 8.2.1. Left atrial appendage closure (LAAC)
- 8.2.2. Transcatheter mitral valve repair (TMVr)
- 8.2.3. Transcatheter tricuspid valve repair (TTVr)
- 8.2.4. Valvuloplasty
- 8.2.5. Other repair procedures
- 9. Global Structural Heart Devices Market, By End User (USD Million) 2021-2034
- 9.1. Hospitals
- 9.2. Ambulatory surgical centres
- 9.3. Cardiac catheterization labs
- 9.4. Other end user
- 10. Global Structural Heart Devices Market, (USD Million) 2021-2034
- 10.1. Global Structural Heart Devices Market Size and Market Share
- 11. Global Structural Heart Devices Market, By Region, (USD Million) 2021-2034
- 11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
- 11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
- 11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
- 11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
- 11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America
- 12. Company Profile
- 12.1. Abbott
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. AtriCure
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. BIOMERICS
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. Boston Scientific
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. BRAILE
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. CryoLife
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. Edwards
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. JENAVALVE
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. LEPU MEDICAL
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. LivaNova
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Medtronic
- 12.11.1. Company details
- 12.11.2. Financial outlook
- 12.11.3. Product summary
- 12.11.4. Recent developments
- 12.12. NUMED
- 12.12.1. Company details
- 12.12.2. Financial outlook
- 12.12.3. Product summary
- 12.12.4. Recent developments
- 12.13. Others
- 13. Conclusion
- 14. List of Abbreviations
- 15. Reference Links
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
